{
    "nctId": "NCT02263846",
    "briefTitle": "Investigation of Sex Hormone Levels in Chinese Women With Invasive Breast Cancer",
    "officialTitle": "Investigation of Sex Hormone Levels in Chinese Women With Invasive Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 1183,
    "primaryOutcomeMeasure": "The capability of sex hormones to discriminate between pre- and postmenopausal women with invasive breast cancer measured by four widely used methods and instruments in China.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Invasive breast cancer patients confirmed through pathology.\n* For postmenopausal group: patients at the age \u2265 60 years with more than one year of menopause, or patients having undergone bilateral oophorectomy.\n* For premenopausal group: patients with regular menses during recent 3 months and having never received luteinizing hormone-releasing hormone (LHRH) analogue therapy.\n* Patients who meet the above criteria can be enrolled whether they have received anti-cancer treatment or not.\n\nExclusion Criteria:\n\n* patients less than 60 years old who are amenorrhoeic but have not received bilateral oophorectomy or medical castration.",
    "sex": "FEMALE",
    "minimumAge": "20 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}